Codex DNA Inc (DNAY) Financials

$1.91

$-0.09 (-4.50%)

As on 08-Mar-2023 09:30EDT

Market cap

$38 Mln

Revenue (TTM)

$15 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	15.41	11.04	6.58	--	--	--
Cost of Revenue	11.01	6.74	2.95	--	--	--
Gross Profit	4.39	4.30	3.63	--	--	--
Operating Expenses	60.73	39.67	19.99	--	--	--
Operating Profit (EBIT)	-50.70	-35.37	-16.36	--	--	--
Other Income	0.01	-2.20	--	--	--	--
Profit before Tax	-52.81	-38.94	-18.01	--	--	--
Provision for Tax	0.02	0.01	0.01	--	--	--
Profit after Tax (Net Income)	-52.83	-38.96	-18.01	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-52.83	-38.96	-18.01	-9.96	--	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-105.61	90.78	-25.46	-7.50	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	22.03	15.74	46.70	44.54	--	--
Current Liabilities	12.81	9.73	5.63	1.72	--	--
Total Liabilities	-57.97	116.26	26.86	38.76	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	25.96	23.07	9.68	7.33	--	--
Current Assets	62.19	93.18	17.18	31.43	--	--
Total Assets	100.95	116.26	26.86	38.76	--	--
Total Debt*	21.38	6.30	8.33	4.77	--	--
Net Current Assets	49.38	83.45	11.56	29.71	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-36.70	-15.38	-7.67	--	--
Cash Flow from Investing Activities	--	-15.04	-0.20	-0.09	--	--
Cash from Financing Activities	--	121.08	-0.10	42.13	--	--
Net Cash Inflow / Outflow	--	69.34	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-97.46	181.30	--	--	--
ROE (%)	--	-119.27	109.28	--	--	--
ROA (%)	-45.29	-54.44	-54.89	--	--	--
EBIT Margin (%)	-351.97	-365.05	-263.31	--	--	--
Net Margin (%)	-342.67	-440.60	-273.87	--	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	55.58	0.68	--	--	--	--
EBIT Growth (%)	-75.78	-132.82	-106.84	--	--	--
Net Profit Growth (%)	-64.84	-116.31	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.65	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.13	1.94	--	--	--	--
Close Price ($)	1.66	10.80	--	--	--	--
High Price ($)	12.07	25.70	--	--	--	--
Low Price ($)	1.65	6.16	--	--	--	--
Market Cap ($ Cr)	38.38	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	-0.18	0.07	-0.33	-0.64	--	--
Short term debt to equity ratio	-0.01	0.02	-0.08	-0.01	--	--
Current Ratio	4.86	9.57	3.05	18.25	--	--
Quick Ratio	4.68	9.33	2.95	17.84	--	--
Interest Coverage	-14.89	-29.45	-25.09	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	36.75	33.19	22.69	--	--	--
Asset Turnover	0.13	0.15	0.20	--	--	--
Receivable days	--	85.28	82.87	--	--	--
Inventory Days	--	80.40	81.26	--	--	--
Payable days	--	99.92	111.70	--	--	--
Cash Conversion Cycle	--	65.76	52.42	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.